StockData
BSXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31

BOSTON SCIENTIFIC CORP

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026
$45.05+0.66 (+1.49%)

Close on Oct 19, 2026

Market cap
$66.44B
P/E (TTM)
18.2
Dividend yield
–

BOSTON SCIENTIFIC CORP balance sheet

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
69.9%
Operating margin
19.8%
Net margin
–
Return on equity, FY2025
–

Financial strength

Current ratio
1.24
Debt to equity
0.51
Debt to assets
27.9%
Cash to current liabilities
8.4%

Valuation

P/E ratio
18.2
Price to sales
3.16
Price to book
2.67
Dividend yield
–